Nothing Special   »   [go: up one dir, main page]

WARREN et al., 1961 - Google Patents

Demonstration of 16α-hydroxylase in the human ovary

WARREN et al., 1961

Document ID
13780972636440809932
Author
WARREN J
SALHANICK H
Publication year
Publication venue
The Journal of Clinical Endocrinology & Metabolism

External Links

Snippet

The presence of 16α-hydroxylase in the human ovary was demonstrated by conversion of 4- C14-progesterone to 6α-hydroxyprogesterone in incubations with tissue minces. Increased 16-hydroxylase activity was found in tissues abundant in follicular and thecal elements …
Continue reading at academic.oup.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Similar Documents

Publication Publication Date Title
Mauvais-Jarvis et al. Studies on testosterone metabolism in subjects with testicular feminization syndrome
RICE et al. Steroid hormone formation in the human ovary: IV. Ovarian stromal compartment: formation of radioactive steroids from Acetate-1-14C and action of gonadotropins
Gower 16-unsaturated C19 steroids a review of their chemistry, biochemistry and possible physiological role
Stanczyk et al. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids
Jailer Virilism
LIPMAN et al. An alternate pathway for cortisol metabolism: 6β-hydroxycortisol production by human tissue slices
SAVARD et al. Formation of androgens by human arrhenoblastoma tissue in vitro
WARREN et al. Biosynthesis of estrogens in pregnancy: precursor role of plasma dehydroisoandrosterone
Pincus et al. The intermediate metabolism of the sex hormones
WARREN et al. Demonstration of 16α-hydroxylase in the human ovary
Mauvais-Jarvis et al. In vivo studies on progesterone metabolism by human skin
Van der Wall et al. Inhibition of the in vivo conversion of androstenedione to estrone by the aromatase inhibitor vorozole in healthy postmenopausal women
WIEST et al. Metabolism of progesterone-4-C14 by an arrhenoblastoma
Plotz et al. Enzymatic activities related to steroidogenesis in postmenopausal ovaries of patients with and without endometrial carcinoma
SANDBERG et al. Androgen biosynthesis by ovarian lipoid cell tumor
MacARTHUR et al. Formation of steroids by the equine foetal testis
Pierrepoint et al. Neutral steroid sulphation and oestrogen biosynthesis in vitro by a feminizing Leydig cell tumour of the testis
Vinson et al. A comparison of steroid production in vitro and in vivo by the adrenal gland of the rat
Mulrow et al. Conversion of 17-hydroxy-pregnenolone to cortisol by normal and hyperplastic human adrenal slices
Jungmann et al. In vitro synthesis of estrogens by midterm human placenta and fetal liver
Jailer et al. Adrenal virilism. II. Metabolic studies
Bryson et al. Enzymic steroid conversions in a masculinovoblastoma
Vinson et al. The in vitro production of oestrogens from progesterone by mouse adrenal glands
US4278668A (en) Pure 17 alpha-ethynyl(5 alpha), androst-2-ene,17 beta-cl, process for its preparation and therapeutical applications of the same
Morfin et al. C19‐Steroid Metabolism by Canine Prostate, Epididymis and Perianal Glands: Application of the Twin‐Ion Technique of Gas Chromatography/Mass Spectrometry to Establish 7α‐Hydroxylation